
Lumivib Tablet
Marketer
Vibcare Pharma Pvt Ltd
Salt Composition
Artemether (80mg) + Lumefantrine (480mg)
Overview Lumivib Tablet
Malarone tablets effectively combat malaria in patients of all ages. This dual-action medication comprises two antimalarial drugs. Importantly, it's solely for treating existing malaria; it doesn't prevent infection nor address severe cases impacting vital organs like the brain, lungs, or kidneys. Malarone functions by eliminating the malaria parasite, halting disease progression. Optimal absorption necessitates ingestion with food. Always adhere precisely to your physician's prescribed dosage and duration; exceeding the recommended amount risks adverse reactions. Complete the entire course to ensure complete parasite eradication. Common side effects include headache, appetite loss, fatigue, arthralgia, and myalgia; dizziness may also occur. Report persistent or intensifying side effects to your doctor. Disclose all current medications to your doctor before commencing treatment. Pregnant or lactating individuals should only use this medication under strict medical supervision due to potential harm to the fetus or infant.
Uses of Lumivib Tablet
Managing Malaria Infections
Major Benefits of Lumivib Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the Lumivib Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Lumivib Tablet:
- Headache
- Loss of appetite
- Dizziness
- Weakness
- Joint pain
- Muscle pain
How to use Lumivib Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the Lumivib Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
How Lumivib Tablet works:
Artemether and lumefantrine, the active components of Lumivib Tablet, provide a dual-action approach to malaria treatment. Their combined effect elevates blood haem levels, a compound lethal to the malaria parasite. This heightened toxicity eliminates the parasite, thus halting disease progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Lumivib Tablet lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Lumivib Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks before prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Lumivib Tablet safely. Available data from human studies indicates minimal risk to the infant.
DrivingUNSAFE
Taking Lumivib tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Exercise caution when prescribing Lumivib Tablet to individuals with severe kidney impairment; dosage modification may be necessary. A physician's consultation is advised. Severe kidney disease does not necessitate dosage alteration.
LiverCAUTION
Patients with severe hepatic impairment should use Lumivib Tablet cautiously. Dosage modification for Lumivib Tablet may be necessary; physician consultation is advised. No dosage alteration is suggested for individuals with severe liver dysfunction.
What if you forget to take Lumivib Tablet :
Should you forget a Lumivib Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Lumivib Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimalarial Medications |
